NSE: BIOCON | BSE: 532523

Slowing Down Stock

Download real time

316.55 10.25 (3.35%)

3.3M NSE+BSE Volume

NSE 11 Apr, 2025 3:31 PM (IST)

38,005

Market Cap

Market Leader

US FDA Approval

Biocon receives USFDA approval for Jobevne, used in cancer treatment, with a market size of ~$2 bn See details

Biocon Ltd. Delivery Percentage and Volume Analysis for NSE and BSE as of 13 Apr, 2025

Biocon Ltd. Delivery Traded Volume, Percentages, Week Average and Analysis for NSE and BSE as of 13 Apr, 2025

Date

BSE NSE NSE + BSE

Delivery Stock Screeners